The antibacterial medicine sales in Chile are forecasted to show a consistent upward trend from 2024 to 2028. The value is expected to rise from 240.8 million USD PPP in 2024 to 263.9 million USD PPP in 2028. This represents an incremental increase each year, indicating a steady growth trajectory for the market. When reviewing the data for previous years, the sales value for 2023 stood at 235.0 million USD PPP.
Year-on-year variations for the forecasted years are as follows:
- 2024 to 2025: 2.41%
- 2025 to 2026: 2.35%
- 2026 to 2027: 2.30%
- 2027 to 2028: 2.20%
Over the last five years, the compound annual growth rate (CAGR) averages around 2.32%, reflecting a consistent but moderate upward trend in sales.
Future trends to watch for include advancements in antibiotic formulations, potential shifts in government healthcare policies, and global resistance to antibiotics affecting market dynamics. Monitoring these factors can provide more comprehensive insights into the market's future direction.
